Kailera Therapeutics, Inc. (KLRA) Form 10-K Annual Reports
Kailera Therapeutics, Inc. (KLRA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KLRA
CIK: 2096997
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMichael Donovan
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-09 | 2026-09-07 | 4 | 0001193125-26-386782 | View SEC Doc Filr Page |
| 3 | 2026-09-09 | 2026-08-31 | 3 | 0001193125-26-386778 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001193125-26-352133 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001493215-26-000151 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-346958 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-346919 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-05 | — | SCHEDULE 13G Filing | 0001104659-26-090642 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 | 0001193125-26-298558 | View SEC Doc Filr Page |
| 3 | 2026-07-08 | 2026-06-29 | 3 | 0001193125-26-298547 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | 4 | 0001193125-26-267493 | View SEC Doc Filr Page |
| 10-Q | 2026-05-26 | 2026-03-31 | 10-Q | 0001193125-26-239417 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-26 | 8-K | 0001193125-26-239362 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-04-23 | — | SCHEDULE 13D Filing | 0001193125-26-174330 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-04-23 | — | SCHEDULE 13D Filing | 0001193125-26-174293 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-20 | 4 Filing | 0001231919-26-000390 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-20 | OWNERSHIP DOCUMENT | 0001104659-26-046276 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-20 | 4 | 0001193125-26-164417 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | 4 | 0001193125-26-164407 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-20 | 4 | 0001193125-26-164389 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | 4 | 0001193125-26-164388 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | 4 | 0001193125-26-164307 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | 4 | 0001193125-26-164306 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | 4 | 0001193125-26-164299 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | 4 | 0001193125-26-164275 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | 4 | 0001193125-26-164271 | View SEC Doc Filr Page |